Compare SCYX & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCYX | AVX |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 30.8M |
| IPO Year | 2014 | 2020 |
| Metric | SCYX | AVX |
|---|---|---|
| Price | $3.79 | $4.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $36.33 | N/A |
| AVG Volume (30 Days) | ★ 284.7K | 245.0K |
| Earning Date | 11-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.36 | ★ 92.55 |
| EPS | ★ N/A | N/A |
| Revenue | $257,000.00 | ★ $2,340,811.00 |
| Revenue This Year | N/A | $18,042.77 |
| Revenue Next Year | $977.86 | $12.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3348.10 |
| 52 Week Low | $0.66 | $0.35 |
| 52 Week High | $6.09 | $7.38 |
| Indicator | SCYX | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 39.78 | 44.13 |
| Support Level | $3.53 | $3.02 |
| Resistance Level | $4.30 | $6.25 |
| Average True Range (ATR) | 0.23 | 0.65 |
| MACD | -0.02 | -0.18 |
| Stochastic Oscillator | 23.92 | 16.50 |
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
AVAX One Technology Ltd is a digital infrastructure company focused on digital asset and computing infrastructure. The Company builds modular data centers in regions with access to energy resources, using behind-the-meter generation and microgrid design to provide compute capacity for AI and high-performance computing (HPC) workloads. In addition, the company mines Bitcoin in Alberta and Ohio, operating at a hashrate of approximately 300 PH/s. The Company also maintains an Avalanche digital asset treasury, accumulating AVAX and generating onchain yield through native staking and ecosystem participation.